rss
Br J Ophthalmol 90:847-851 doi:10.1136/bjo.2005.088104
  • Clinical science
    • Extended reports

The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India

Table 2

 Mean spherical equivalent refractive error in the treatment and placebo groups over time

Treatment group Mean spherical equivalent (95% CI)
Baseline Year 1 Year 2 Year 3 Year 4 Year 5
Patients were excluded from this table if they were pseudophakic.) There were no significant differences between the two groups
Nine subjects reached the “failure of treatment” end point, three in the placebo group and six in the antioxidant group (p = 0.51).
Placebo group −0.13 (−0.19 to −0.06) −0.22 (−0.29 to −0.14) −0.29 (−0.37 to −0.21) −0.21 (−0.29 to −0.14) −0.31 (−0.40 to −0.21) −0.26 (−0.35 to −0.18)
Vitamin group −0.07 (−0.12 to −0.03) −0.17 (−0.21 to −0.11) −0.16 (−0.23 to −0.11) −0.13 (−0.19 to −0.08) −0.17 (−0.24 to −0.09) −0.52 (−0.34 to −0.18)

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.